# Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex, IHC (Histoglob) in Chronic Urticaria

> **NCT07680413** · — · COMPLETED · sponsor: **Bharat Serums and Vaccines Limited** · enrollment: 660 (actual)

## Conditions studied

- Chronic Urticaria

## Interventions

- **DRUG:** Antihistaminics, H2 blockers, Leukotriene antagonists, Immunoglobulin/Histamine Complex (IHC) Injection

## Key facts

- **NCT ID:** NCT07680413
- **Lead sponsor:** Bharat Serums and Vaccines Limited
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-12-31
- **Primary completion:** 2026-08-03
- **Final completion:** 2026-08-03
- **Target enrollment:** 660 (ACTUAL)
- **Last updated:** 2026-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07680413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07680413, "Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex, IHC (Histoglob) in Chronic Urticaria". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07680413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*